The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 3,810 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 578 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
| ALEXION PHARMACEUTICALS INC | COM | 015351109 | 2,694 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 800 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
| AMERISOURCEBERGEN CORP | COM | 03073E105 | 2,655 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| ANTARES PHARMA INC | COM | 036642106 | 1,180 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 3,351 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| CARDINAL HEALTH INC | COM | 14149Y108 | 3,596 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 1,590 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 636 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| CVS HEALTH CORP | COM | 126650100 | 1,483 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| DIREXION SHS ETF TR | DRX S&P500BULL | 25459W862 | 3,126 | 120,000 | SH | Call | SOLE | 120,000 | 0 | 0 | |
| GILEAD SCIENCES INC | COM | 375558103 | 3,738 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 3,738 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| GLAXOSMITHKLINE PLC | SPONSORED ADR | 37733W105 | 3,789 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| GREENLANE HLDGS INC | CL A | 395330103 | 387 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 2,992 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| LABORATORY CORP AMER HLDGS | COM NEW | 50540R409 | 3,160 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| MCKESSON CORP | COM | 58155Q103 | 3,382 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| MENLO THERAPEUTICS INC | COM | 586858102 | 2,278 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
| PROSHARES TR | ULTRAPRO SHORT S | 74347B268 | 1,809 | 75,000 | SH | Call | SOLE | 75,000 | 0 | 0 | |
| PROSHARES TR | ULTRAPRO SHORT S | 74347B268 | 3,618 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| PROSHARES TR | ULTSH NASD BIOT | 74347B789 | 1,058 | 75,000 | SH | Call | SOLE | 75,000 | 0 | 0 | |
| TYME TECHNOLOGIES INC | COM | 90238J103 | 2,393 | 2,175,000 | SH | SOLE | 2,175,000 | 0 | 0 | ||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 468 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| WALGREENS BOOTS ALLIANCE INC | COM | 931427108 | 1,144 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||